Filamentous Hemagglutinin of <i>Bordetella pertussis</i> Does Not Interact with the β<sub>2</sub> Integrin CD11b/CD18

Filamentous Hemagglutinin of <i>Bordetella pertussis</i> Does Not Interact with the β<sub>2</sub> Integrin CD11b/CD18

The pertussis agent <i>Bordetella pertussis</i> produces a number of virulence factors, of which the filamentous hemagglutinin (FhaB) plays a role in <i>B. pertussis</i> adhesion to epithelial and phagocytic cells. Moreover, FhaB was recently found to play a crucial role in n...

Full description

Bibliographic Details
Main Authors:	Maryam Golshani, Waheed Ur Rahman, Adriana Osickova, Jana Holubova, Jinery Lora, Nataliya Balashova, Peter Sebo, Radim Osicka
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	International Journal of Molecular Sciences
Subjects:	adenylate cyclase toxin <i>Bordetella pertussis</i> CD11b/CD18 filamentous hemagglutinin heparin integrin
Online Access:	https://www.mdpi.com/1422-0067/23/20/12598

Similar Items

Selective Enhancement of the Cell-Permeabilizing Activity of Adenylate Cyclase Toxin Does Not Increase Virulence of <i>Bordetella pertussis</i>
by: Jana Holubova, et al.
Published: (2021-10-01)

Characterization of Post-Translational Modifications and Cytotoxic Properties of the Adenylate-Cyclase Hemolysin Produced by Various Bordetella pertussis and Bordetella parapertussis Isolates
by: Valérie Bouchez, et al.
Published: (2017-09-01)

<i>Bordetella</i> Adenylate Cyclase Toxin Elicits Airway Mucin Secretion through Activation of the cAMP Response Element Binding Protein
by: Anna Malandra, et al.
Published: (2021-08-01)

Characterization of the Intrinsic Phospholipase A1 Activity of <i>Bordetella pertussis</i> Adenylate Cyclase Toxin
by: David González-Bullón, et al.
Published: (2018-12-01)

Delivery of Mycobacterium tuberculosis epitopes by Bordetella pertussis adenylate cyclase toxoid expands HLA-E-restricted cytotoxic CD8+ T cells
by: Giusto D. Badami, et al.
Published: (2023-12-01)

Bioengineering of <i>Bordetella pertussis</i> Adenylate Cyclase Toxin for Vaccine Development and Other Biotechnological Purposes
by: Daniel Ladant
Published: (2021-01-01)

Expression of <i>Bordetella pertussis</i> Antigens Fused to Different Vectors and Their Effectiveness as Vaccines
by: Han Xu, et al.
Published: (2021-05-01)

Membrane Activity and Channel Formation of the Adenylate Cyclase Toxin (CyaA) of <i>Bordetella pertussis</i> in Lipid Bilayer Membranes
by: Oliver Knapp, et al.
Published: (2020-03-01)

Adenylate Cyclase Toxin Tinkering With Monocyte-Macrophage Differentiation
by: Jawid Nazir Ahmad, et al.
Published: (2020-09-01)

The Adenylate Cyclase (CyaA) Toxin from <i>Bordetella pertussis</i> Has No Detectable Phospholipase A (PLA) Activity In Vitro
by: Alexis Voegele, et al.
Published: (2019-02-01)

Design of a Quantitative LC-MS Method for Residual Toxins Adenylate Cyclase Toxin (ACT), Dermonecrotic Toxin (DNT) and Tracheal Cytotoxin (TCT) in <em>Bordetella pertussis</em> Vaccines
by: Lisa Szymkowicz, et al.
Published: (2021-10-01)

Bordetella pertussis and Bordetella bronchiseptica filamentous hemagglutinins are processed at different sites
by: David Jurnecka, et al.
Published: (2018-08-01)

Structure–Function Relationships Underlying the Capacity of Bordetella Adenylate Cyclase Toxin to Disarm Host Phagocytes
by: Jakub Novak, et al.
Published: (2017-09-01)

Pasteurian Contributions to the Study of <i>Bordetella pertussis</i> Toxins
by: Camille Locht
Published: (2023-02-01)

Bordetella Pertussis Adenylate Cyclase Toxin Does Not Possess a Phospholipase A Activity; Serine 606 and Aspartate 1079 Residues Are Not Involved in Target Cell Delivery of the Adenylyl Cyclase Enzyme Domain
by: Ladislav Bumba, et al.
Published: (2018-06-01)

<italic toggle="yes">Bordetella</italic> Adenylate Cyclase Toxin Inhibits Monocyte-to-Macrophage Transition and Dedifferentiates Human Alveolar Macrophages into Monocyte-like Cells
by: Jawid Nazir Ahmad, et al.
Published: (2019-10-01)

Acellular Pertussis Vaccine Inhibits <i>Bordetella pertussis</i> Clearance from the Nasal Mucosa of Mice
by: Jana Holubová, et al.
Published: (2020-11-01)

Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin
by: Margaret M. Williams, et al.
Published: (2016-02-01)

New Data on Vaccine Antigen Deficient Bordetella pertussis Isolates
by: Valérie Bouchez, et al.
Published: (2015-09-01)

Bioengineering of Bordetella pertussis Adenylate Cyclase Toxin for Antigen-Delivery and Immunotherapy
by: Alexandre Chenal, et al.
Published: (2018-07-01)

Bordetella Adenylate Cyclase-Hemolysin Toxins
by: Nicole Guiso
Published: (2017-09-01)

Reduced Bordetella pertussis-specific CD4+ T-Cell Responses at Older Age
by: Eleonora E. Lambert, et al.
Published: (2022-02-01)

Transmission of Bordetella holmesii during Pertussis Outbreak, Japan
by: Hajime Kamiya, et al.
Published: (2012-07-01)

Bordetella adenylate cyclase toxin is a unique ligand of the integrin complement receptor 3
by: Radim Osicka, et al.
Published: (2015-12-01)

Development of sandwich ELISA-based assays for screening Bordetella pertussis antigens expressed in the bacterial cell culture
by: Gilda Lemos-Pérez, et al.
Published: (2015-09-01)

The Potential Role of Subclinical Bordetella pertussis Infection in Epilepsy
by: Keith Rubin, et al.
Published: (2019-08-01)

Fha Deficient Bordetella pertussis Isolates in Iran with 50 Years Whole Cell Pertussis Vaccination
by: Samaneh Saedi, et al.
Published: (2021-07-01)

FEATURES OF GENOTYPiNG VARIABILITY OF STRAINS OF BORDETELLA PERTUSSIS ALLOCATED FROM PATIENTS WITH WHOOPING COUGH IN RUSSIA
by: V. A. Aleshkin, et al.
Published: (2012-09-01)

Changes in genetic diversity of the Bordetella pertussis population in Serbia between 1953 and 2011
by: Plješa Tatjana, et al.
Published: (2014-01-01)

SUSCEPTIBILITY OF BORDETELLA PERTUSSIS STRAINS TO ANTIBACTERIAL PREPARATIONS
by: O. Yu. Borisova, et al.
Published: (2015-08-01)

Infection by Bordetella pertussis and Bordetella parapertussis in cases of suspected whooping cough (2011-2015) in Mar del Plata, Argentina
by: Silvina Lavayén, et al.
Published: (2017-03-01)

Laboratory-based surveillance of pertussis using multitarget real-time PCR in Japan: evidence for Bordetella pertussis infection in preteens and teens
by: K. Kamachi, et al.
Published: (2015-11-01)

Structure of Population of Strains of the Bordetella pertussis in the Russia
by: O. Yu. Borisova, et al.
Published: (2016-08-01)

Macrolide Resistance in <i>Bordetella pertussis</i>: Current Situation and Future Challenges
by: Lauri Ivaska, et al.
Published: (2022-11-01)

Pertussis vaccines and the role of <I>Bordetella pertussis</I> lipooligosaccharide in the immune response to pertussis infection and vaccination
by: I. A. Alekseeva, et al.
Published: (2021-03-01)

<i>Bordetella holmesii</i> Lipopolysaccharide Hide and Seek Game with Pertussis: Structural Analysis of the O-Specific Polysaccharide and the Core Oligosaccharide of the Type Strain ATCC 51541
by: Karolina Ucieklak, et al.
Published: (2020-09-01)

Sensitivity of biofilms of vaccine and freshly isolated <i>Bordetella pertussis</i> strains to antibiotics
by: E. M. Zaytsev, et al.
Published: (2021-01-01)

Clinical, laboratorial and radiographic predictors of Bordetella pertussis infection
by: Camila Vieira Bellettini, et al.
Published: (2014-12-01)

Uncovering Distinct Primary Vaccination-Dependent Profiles in Human <i>Bordetella pertussis</i> Specific CD4+ T-Cell Responses Using a Novel Whole Blood Assay
by: Eleonora E. Lambert, et al.
Published: (2020-05-01)

A Robust and Sensitive Spectrophotometric Assay for the Enzymatic Activity of Bacterial Adenylate Cyclase Toxins
by: Marilyne Davi, et al.
Published: (2022-10-01)